Modulation of outward potassium currents in aligned cultures of neonatal rat ventricular myocytes during phorbol ester-induced hypertrophy.
Protein kinase C-stimulating phorbol esters induce a strong hypertrophic response when applied in vitro to cardiac ventricular myocytes. The aim of this study was to determine if this in vitro model of hypertrophy is associated with changes in the expression of voltage-gated K(+)channels. Myocytes were isolated from 3--4-day-old neonatal rats and cultured on aligned collagen thin gels. Membrane currents were measured with the use of the whole-cell arrangement of the patch clamp technique and the expression levels of the Kv1.4, Kv4.2 and Kv2.1 alpha subunits quantified using Western blot analysis. Voltage steps positive to -30 mV resulted in the activation of both a transient (I(to)) and a sustained (I(sus)) component of outward K(+)current in the aligned myocytes. Overnight exposure to phorbol 12-myristate 13-acetate (PMA) caused a 55% increase in myocyte size and a three-fold reduction in the peak amplitude of I(to). No differences in the half-maximal voltages required for activation and steady-state inactivation were observed between I(to)measured in control and PMA-treated myocytes. In contrast, PMA treatment resulted in a 62% increase in a tetraethylammonium-sensitive component of I(sus)(TEA-I(sus)) and was associated with the appearance of a slow component of current decay. Expression levels of the Kv1.4 and Kv4.2 alpha subunits were strongly depressed in the hypertrophic myocytes, while the density of the Kv2.1 alpha subunit was enhanced. PMA-induced changes in the Kv alpha subunits were partially prevented through inhibition of the mitogen-activated protein kinase (MAPK) pathway. Thus, PMA-induced hypertrophy of cultured ventricular myocytes is associated with an altered expression of voltage-gated K(+)channels.
Walsh
K B
KB
Department of Pharmacology & Physiology, University of South Carolina, School of Medicine, Columbia, SC 29209, USA. walsh@med.sc.edu
Sweet
J K
JK
Parks
G E
GE
Long
K J
KJ
D000818:Animals; D006332:Cardiomegaly / Q000378:metabolism*; D002478:Cells, Cultured; D051668:Delayed Rectifier Potassium Channels; D004553:Electric Conductivity; D004594:Electrophysiology; D006352:Heart Ventricles / Q000166:cytology / Q000378:metabolism*; D051665:Kv1.4 Potassium Channel; D008934:Mitogens / Q000494:pharmacology; D026902:Potassium Channel Blockers; D015221:Potassium Channels / Q000096:biosynthesis / Q000378:metabolism* / Q000502:physiology; D024642:Potassium Channels, Voltage-Gated; D051381:Rats; D051669:Shab Potassium Channels; D051672:Shal Potassium Channels; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D019789:Tetraethylammonium / Q000494:pharmacology
D051668:Delayed Rectifier Potassium Channels; C496979:Kcna4 protein, rat; C496991:Kcnb1 protein, rat; C497020:Kcnd2 protein, rat; D051665:Kv1.4 Potassium Channel; D008934:Mitogens; D026902:Potassium Channel Blockers; D015221:Potassium Channels; D024642:Potassium Channels, Voltage-Gated; D051669:Shab Potassium Channels; D051672:Shal Potassium Channels; D019789:Tetraethylammonium; D013755:Tetradecanoylphorbol Acetate